id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-6529-0002,FDA,FDA-2017-N-6529,List of References re The Food and Drug Administration’s Approach To Evaluating Nicotine Replacement Therapies; Public Hearing; Request for Comments,Supporting & Related Material,Background Material,2017-11-30T05:00:00Z,2017,11,,,2017-11-30T16:38:25Z,,0,0,0900006482cc3c66
FDA-2017-N-6529-0003,FDA,FDA-2017-N-6529,Reference 1 Quitting smoking among adults - United States 2000-2015 re The Food and Drug Administration’s Approach To Evaluating Nicotine Replacement Therapies; Public Hearing; Request for Comments,Supporting & Related Material,Background Material,2017-11-30T05:00:00Z,2017,11,,,2017-11-30T16:42:20Z,,0,0,0900006482cc3c67
FDA-2017-N-6529-0005,FDA,FDA-2017-N-6529,Reference 3 Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation re The Food and Drug Administration’s Approach To Evaluating Nicotine Replacement Therapies; Public Hearing; Request for Comments,Supporting & Related Material,Background Material,2017-11-30T05:00:00Z,2017,11,,,2017-11-30T16:47:53Z,,0,0,0900006482cc3c69
FDA-2017-N-6529-0004,FDA,FDA-2017-N-6529,Reference 2 Nicotine replacement therapty for long term smoking cessation a meta-analysis (1) re The Food and Drug Administration’s Approach To Evaluating Nicotine Replacement Therapies; Public Hearing; Request for Comments,Supporting & Related Material,Background Material,2017-11-30T05:00:00Z,2017,11,,,2017-11-30T16:44:44Z,,0,0,0900006482cc3c68
FDA-2017-N-6529-0001,FDA,FDA-2017-N-6529,"The Food and Drug Administration’s Approach To Evaluating Nicotine
Replacement Therapies; Public Hearing; Request for Comments",Proposed Rule,Request for Comment,2017-11-30T05:00:00Z,2017,11,2017-11-30T05:00:00Z,2018-02-16T04:59:59Z,2018-02-24T02:01:10Z,2017-25671,0,0,0900006482cc0a02